Learning Outcome: The course aims to provide students with the knowledge of the mechanisms underlying cancer immunotherapy and the mechanisms with which the main biotechnological drugs interact with their molecular targets in cancer. In this way, the student will be able to understand the rationale for the use of the various classes of drugs in clinical practice. Face to face lectures are integrated with the use of web technologies. The student will be asked to discuss recent findings and/or scientific papers individually and through group collaboration. Content: As part of the educational objectives for students of the Master Degree Course in CTF, the teaching of Immuno-oncology intends to contribute to the formation of those scientific skills necessary to operate in public and private research laboratories as well as in the Biotechnological, Pharmaceutical and Biomedical industrial sector, providing knowledge of immunotherapy for cancer. In particular, the learning objectives are aimed at acquiring in-depth knowledge of the mechanism of action of different groups of new generation biotechnological drugs and the rationale for their use in immunotherapy. Course Delivery Term: II Semester (Summer): March – May Teaching Methods: Frontal lectures will be integrated using web technologies as well as individual and group exercises in which the student will be asked to study and discuss topics relating to immunotherapy and biotechnological drugs. Assessment: Oral Examination Location: Department of Pharmacy